Koers Ekso Bionics Holdings Inc OTC Bulletin Board
Aandelen
EKSO
US2826441030
Geavanceerde medische apparatuur & technologie
Omzet 2024 * | 21,54 mln. 19,83 mln. | Omzet 2025 * | 27,81 mln. 25,6 mln. | Marktkapitalisatie | 23,99 mln. 22,08 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -8 mln. -7,36 mln. | Nettowinst (verlies) 2025 * | -4 mln. -3,68 mln. | EV/omzet 2024 * | 1,11 x |
Nettoliquiditeiten 2024 * | - 0 | Nettoliquiditeiten 2025 * | - 0 | EV/omzet 2025 * | 0,86 x |
K/w-verhouding 2024 * |
-3,07
x | K/w-verhouding 2025 * |
-6,95
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 90,79% |
Recentste transcriptie over Ekso Bionics Holdings Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Scott Davis
CEO | Chief Executive Officer | 54 | 01-04-21 |
Jerome Wong
DFI | Director of Finance/CFO | 50 | 01-05-17 |
Jason Jones
COO | Chief Operating Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Corinna Lathan
BRD | Director/Board Member | 57 | 25-12-21 |
Rhonda Wallen
BRD | Director/Board Member | 57 | 29-12-20 |
Mary Cloyd
BRD | Director/Board Member | 69 | 29-12-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+11,18% | 225 mld. | |
+15,22% | 197 mld. | |
+19,19% | 143 mld. | |
+30,89% | 111 mld. | |
+1,56% | 64,72 mld. | |
+18,48% | 54,44 mld. | |
+5,12% | 51,06 mld. | |
+10,53% | 45,03 mld. | |
+5,98% | 37,4 mld. |